Kuros Biosciences Pink Sheet Forecast - Simple Exponential Smoothing
| CSBTF Stock | USD 34.65 3.69 9.62% |
The Simple Exponential Smoothing forecasted value of Kuros Biosciences AG on the next trading day is expected to be 34.66 with a mean absolute deviation of 0.19 and the sum of the absolute errors of 11.51. Kuros Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Kuros Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
The relative strength index (RSI) of Kuros Biosciences' share price is below 30 as of 23rd of January 2026 suggesting that the pink sheet is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Kuros Biosciences AG, making its price go up or down. Momentum 20
Sell Stretched
Oversold | Overbought |
Using Kuros Biosciences hype-based prediction, you can estimate the value of Kuros Biosciences AG from the perspective of Kuros Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Kuros Biosciences AG on the next trading day is expected to be 34.66 with a mean absolute deviation of 0.19 and the sum of the absolute errors of 11.51. Kuros Biosciences after-hype prediction price | USD 34.65 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kuros |
Kuros Biosciences Additional Predictive Modules
Most predictive techniques to examine Kuros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kuros using various technical indicators. When you analyze Kuros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kuros Biosciences Simple Exponential Smoothing Price Forecast For the 24th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Kuros Biosciences AG on the next trading day is expected to be 34.66 with a mean absolute deviation of 0.19, mean absolute percentage error of 0.40, and the sum of the absolute errors of 11.51.Please note that although there have been many attempts to predict Kuros Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kuros Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kuros Biosciences Pink Sheet Forecast Pattern
| Backtest Kuros Biosciences | Kuros Biosciences Price Prediction | Buy or Sell Advice |
Kuros Biosciences Forecasted Value
In the context of forecasting Kuros Biosciences' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kuros Biosciences' downside and upside margins for the forecasting period are 32.65 and 36.66, respectively. We have considered Kuros Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Kuros Biosciences pink sheet data series using in forecasting. Note that when a statistical model is used to represent Kuros Biosciences pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.357 |
| Bias | Arithmetic mean of the errors | 0.0294 |
| MAD | Mean absolute deviation | 0.1919 |
| MAPE | Mean absolute percentage error | 0.0053 |
| SAE | Sum of the absolute errors | 11.5136 |
Predictive Modules for Kuros Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kuros Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kuros Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kuros Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Kuros Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kuros Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kuros Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kuros Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Kuros Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kuros Biosciences' historical news coverage. Kuros Biosciences' after-hype downside and upside margins for the prediction period are 32.65 and 36.65, respectively. We have considered Kuros Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kuros Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Kuros Biosciences is based on 3 months time horizon.
Kuros Biosciences Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kuros Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kuros Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kuros Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 2.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
34.65 | 34.65 | 0.00 |
|
Kuros Biosciences Hype Timeline
Kuros Biosciences is currently traded for 34.65. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kuros is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.2%. %. The volatility of related hype on Kuros Biosciences is about 0.0%, with the expected price after the next announcement by competition of 34.65. About 35.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Kuros Biosciences recorded a loss per share of 0.24. The entity had not issued any dividends in recent years. The firm had 1:100 split on the 23rd of June 2016. Assuming the 90 days horizon the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Kuros Biosciences to cross-verify your projections.Kuros Biosciences Related Hype Analysis
Having access to credible news sources related to Kuros Biosciences' direct competition is more important than ever and may enhance your ability to predict Kuros Biosciences' future price movements. Getting to know how Kuros Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kuros Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CSPHF | CStone Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.03) | 0.00 | 0.00 | 22.47 | |
| SNBIF | SanBio Company Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PHMMF | Pharma Mar SAU | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 7.16 | |
| PPTDF | PeptiDream | 0.00 | 0 per month | 0.00 | (0.03) | 5.00 | (6.15) | 20.35 | |
| ASCLF | Ascletis Pharma | 0.00 | 0 per month | 3.81 | 0.11 | 12.11 | (4.69) | 52.45 | |
| PHGUF | Pharming Group NV | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 27.50 | |
| NURPF | Neuren Pharmaceuticals Limited | 0.00 | 0 per month | 0.00 | 0.03 | 3.53 | 0.00 | 25.08 | |
| CHIZF | China Traditional Chinese | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NPPNY | Nippon Shinyaku Co | 0.00 | 0 per month | 6.49 | 0.1 | 8.72 | (3.44) | 189.41 | |
| MEOBF | Mesoblast | 0.00 | 0 per month | 0.00 | 0.01 | 0.00 | 0.00 | 57.06 |
Other Forecasting Options for Kuros Biosciences
For every potential investor in Kuros, whether a beginner or expert, Kuros Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kuros Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kuros. Basic forecasting techniques help filter out the noise by identifying Kuros Biosciences' price trends.Kuros Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kuros Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Kuros Biosciences could also be used in its relative valuation, which is a method of valuing Kuros Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kuros Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Kuros Biosciences pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kuros Biosciences shares will generate the highest return on investment. By undertsting and applying Kuros Biosciences pink sheet market strength indicators, traders can identify Kuros Biosciences AG entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 34.65 | |||
| Day Typical Price | 34.65 | |||
| Price Action Indicator | (1.85) | |||
| Period Momentum Indicator | (3.69) | |||
| Relative Strength Index | 20.21 |
Kuros Biosciences Risk Indicators
The analysis of Kuros Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kuros Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kuros pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.7447 | |||
| Standard Deviation | 1.99 | |||
| Variance | 3.95 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Kuros Biosciences
The number of cover stories for Kuros Biosciences depends on current market conditions and Kuros Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kuros Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kuros Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Kuros Biosciences Short Properties
Kuros Biosciences' future price predictability will typically decrease when Kuros Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kuros Biosciences AG often depends not only on the future outlook of the potential Kuros Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kuros Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.8 M | |
| Shares Float | 21.6 M |
Other Information on Investing in Kuros Pink Sheet
Kuros Biosciences financial ratios help investors to determine whether Kuros Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kuros with respect to the benefits of owning Kuros Biosciences security.